Furiex Pharmaceuticals (FURX) -27% premarket after the company says the FDA requested further...

|About: Furiex Pharmaceuticals, Inc. (FURX)|By:, SA News Editor

Furiex Pharmaceuticals (FURX) -27% premarket after the company says the FDA requested further data from partner Takeda Pharmaceutical (TKPYY.PK) regarding the new drug applications for alogliptin and the fixed-dose combination therapy alogliptin and pioglitazone.